The role of the ketogenic diet in the treatment of epilepsy in children and adolescents - a review of the literature
Year: 2025
Type: article
Abstract: Introduction: Epilepsy affects around 50 million people worldwide and is marked by recurrent seizures due to abnormal brain activity. While anticonvulsant medication (ASM) is the standard treatment, about 30% of patients develop drug-resistant epilepsy (DRE), requiring alternative therapies. One such approach is the ketogenic diet (KD), a high-fat, low-carbohydrate regimen that mimics fasting metabolism. Recent research has explored its mechanisms and efficacy in epilepsy management. Aim of the Study: This study evaluates the effectiveness and mechanisms of KD in treating drug-resistant epilepsy in children and adolescents. Materials and Methods: A PubMed analysis was conducted using keywords: ketogenic diet, epilepsy, drug-resistant epilepsy, seizure control, metabolic therapy. Basic Results: Studies confirm KD’s ability to reduce seizure frequency and severity in children with DRE. Over 50% of patients on KD show significant seizure reduction, with some achieving complete freedom. Though side effects like gastrointestinal discomfort and dyslipidemia occur, they are generally manageable. EEG studies suggest KD improves epileptiform discharges, offering broader neurological benefits. Conclusion: KD is a proven, effective therapy for DRE in children, working through increased GABAergic inhibition, metabolic shifts, and neuroprotection. Clinical trials show its ability to reduce seizures, enhance cognition, and improve EEG patterns. While adherence can be difficult, modified versions like MAD offer flexibility. KD’s long-term safety is acceptable, with manageable side effects. Future research should explore its potential as a primary therapy, reducing reliance on ASMs.
Source: Archiv Euromedica
Institutions: University of Rzeszów, Medical University of Silesia
Language: English
Topic: Diet and metabolism studies
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409853545
